• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期抗生素暴露会加重与代谢功能障碍相关的脂肪性肝病相关的肝细胞癌。

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma.

机构信息

Department of Clinical Laboratory, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing, Jiangsu, China.

Key Laboratory for Experimental Teratology of Ministry of Education, Key Laboratory of Infection and Immunity of Shandong Province and Department of Immunology, School of Basic Medical Sciences, Cheeloo Medical College of Shandong University, 44 Wenhua Xi Road, Jinan, Shandong, 250012, P.R. China.

出版信息

BMC Cancer. 2024 Nov 6;24(1):1358. doi: 10.1186/s12885-024-13136-2.

DOI:10.1186/s12885-024-13136-2
PMID:39506660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11539558/
Abstract

BACKGROUND

Metabolic dysfunction-associated steatotic liver disease (MASLD) asscociated hepatocellular carcinoma (HCC) is becoming a growing concern in global healthcare. The early-life gut microbiota plays a crucial role in maintaining healthy. However, the impact of early-life gut microbiota dysbiosis on the advancement of MASLD-HCC remains inadequately understood.

METHODS

In the present study, we investigated the role of early-life gut microbiota in the development of MASLD-HCC in streptozotocin and high-fat diet (STZ-HFD) induced mouse model. We recorded the body weight and lifespan, and dynamically monitored the level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (T-CHO) and blood glucose in the serum monthly. In addition, we examined various immune cells present in the liver, such as T cells, B cells, NK cells, NKT cells, αβT cells, γδT cells, macrophage and MDSC cells by flow cytometry and conducted liquid chromatography mass spectrometry (LC-MS) based analysis on liver tissue from control and early-life antibiotic exposure mice (early-Abx) MASLD-HCC mice.

RESULTS

We found that early-Abx mice suffered from more severe tumor burden and further confirmed that hepatocytes and immune cells were all disturbed. Importantly, early-life antibiotic exposure alters the liver metabolic profiling especially glycerophospholipids and lipid accumulation. Furthermore, mice exposed to antibiotics in early-life showed disturbances in glucose metabolism and developed insulin resistance.

CONCLUSIONS

Collectively, our findings revealed that early-life antibiotic exposure accelerated the progression of MASLD-HCC by impairing the hepatocytes, immune homeostasis and metabolites persistently, highlighting the importance of the early-life microbiota in the development of MASLD-HCC.

摘要

背景

代谢相关脂肪性肝病(MASLD)相关肝细胞癌(HCC)在全球医疗保健中日益受到关注。早期肠道微生物群在维持健康方面起着至关重要的作用。然而,早期肠道微生物群失调对 MASLD-HCC 进展的影响仍了解不足。

方法

在本研究中,我们研究了早期肠道微生物群在链脲佐菌素和高脂肪饮食(STZ-HFD)诱导的小鼠模型中 MASLD-HCC 发展中的作用。我们记录了体重和寿命,并每月动态监测血清中丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、甘油三酯(TG)、总胆固醇(T-CHO)和血糖水平。此外,我们通过流式细胞术检查了肝脏中存在的各种免疫细胞,如 T 细胞、B 细胞、NK 细胞、NKT 细胞、αβT 细胞、γδT 细胞、巨噬细胞和 MDSC 细胞,并对对照和早期抗生素暴露小鼠(早期-Abx)MASLD-HCC 小鼠的肝组织进行基于液相色谱质谱(LC-MS)的分析。

结果

我们发现早期-Abx 小鼠的肿瘤负担更重,并进一步证实肝细胞和免疫细胞均受到干扰。重要的是,早期抗生素暴露改变了肝脏代谢谱,特别是甘油磷脂和脂质积累。此外,早期暴露于抗生素的小鼠表现出葡萄糖代谢紊乱并发展为胰岛素抵抗。

结论

总之,我们的研究结果表明,早期抗生素暴露通过持续损害肝细胞、免疫稳态和代谢物,加速了 MASLD-HCC 的进展,强调了早期微生物群在 MASLD-HCC 发展中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/35fd5a7a8087/12885_2024_13136_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/294987bfa0be/12885_2024_13136_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/35dad900a04b/12885_2024_13136_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/a1f7852ed717/12885_2024_13136_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/489e66ed4836/12885_2024_13136_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/e6ad88ff4a40/12885_2024_13136_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/35fd5a7a8087/12885_2024_13136_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/294987bfa0be/12885_2024_13136_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/35dad900a04b/12885_2024_13136_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/a1f7852ed717/12885_2024_13136_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/489e66ed4836/12885_2024_13136_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/e6ad88ff4a40/12885_2024_13136_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90f/11539558/35fd5a7a8087/12885_2024_13136_Fig6_HTML.jpg

相似文献

1
Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma.早期抗生素暴露会加重与代谢功能障碍相关的脂肪性肝病相关的肝细胞癌。
BMC Cancer. 2024 Nov 6;24(1):1358. doi: 10.1186/s12885-024-13136-2.
2
Dynamic changes of gut microbiota in mouse models of metabolic dysfunction-associated steatohepatitis and its transition to hepatocellular carcinoma.代谢功能障碍相关脂肪性肝炎小鼠模型中肠道微生物组的动态变化及其向肝细胞癌的转变。
FASEB J. 2024 Jul 15;38(13):e23766. doi: 10.1096/fj.202400573RR.
3
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma.一种用于代谢功能障碍相关脂肪性肝病和肝细胞癌的雄性小鼠模型。
Nat Commun. 2024 Aug 2;15(1):6506. doi: 10.1038/s41467-024-50660-y.
4
Both Maternal High-Fat and Post-Weaning High-Carbohydrate Diets Increase Rates of Spontaneous Hepatocellular Carcinoma in Aged-Mouse Offspring.母体高脂肪和断乳后高碳水化合物饮食均可增加老年小鼠后代自发性肝细胞癌的发生率。
Nutrients. 2024 Aug 22;16(16):2805. doi: 10.3390/nu16162805.
5
Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.益生菌混合物通过调节肝脂代谢和肠道微生物群改善饮食诱导的 MASLD/MASH 小鼠模型。
J Agric Food Chem. 2024 Apr 17;72(15):8536-8549. doi: 10.1021/acs.jafc.3c08910. Epub 2024 Apr 4.
6
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.膳食胆固醇通过调节肠道微生物群和代谢物驱动脂肪肝相关肝癌的发生。
Gut. 2021 Apr;70(4):761-774. doi: 10.1136/gutjnl-2019-319664. Epub 2020 Jul 21.
7
RASSF4 Attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease Progression via Hippo Signaling and Suppresses Hepatocarcinogenesis.RASSF4 通过 Hippo 信号通路减轻代谢相关脂肪性肝病的进展并抑制肝癌发生。
Cell Mol Gastroenterol Hepatol. 2024;18(2):101348. doi: 10.1016/j.jcmgh.2024.04.005. Epub 2024 Apr 30.
8
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).打破障碍:肠道内稳态在代谢相关脂肪性肝病(MASLD)中的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2331460. doi: 10.1080/19490976.2024.2331460. Epub 2024 Mar 21.
9
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression.肝细胞中 miR-33 的缺失可减轻 MASLD-MASH-HCC 的进展。
JCI Insight. 2024 Aug 27;9(19):e168476. doi: 10.1172/jci.insight.168476.
10
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.细胞核内的miR-204-3p可减轻小鼠代谢功能障碍相关脂肪性肝病。
J Hepatol. 2024 Jun;80(6):834-845. doi: 10.1016/j.jhep.2024.01.029. Epub 2024 Feb 6.

引用本文的文献

1
Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation.肠道微生物群与肝细胞癌:代谢产物与免疫治疗调节
Cancer Med. 2025 May;14(9):e70914. doi: 10.1002/cam4.70914.
2
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database.早发性肝癌和肝内胆管癌发病率上升:国家儿童癌症登记数据库分析
Cancers (Basel). 2025 Mar 28;17(7):1133. doi: 10.3390/cancers17071133.
3
Assessing the effect of modifiable risk factors on hepatocellular carcinoma: evidence from a bidirectional Mendelian randomization analysis.

本文引用的文献

1
Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism.脂质纳米颗粒介导的 CRISPR-Cas9 递送通过调节 CD36 及其甘油磷脂代谢改善非酒精性脂肪肝病。
Adv Sci (Weinh). 2024 Aug;11(31):e2400493. doi: 10.1002/advs.202400493. Epub 2024 Jun 18.
2
Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma.蛋白激酶:非酒精性脂肪性肝病衍生肝细胞癌发病机制和治疗中的关键因素。
Metabolism. 2023 Oct;147:155665. doi: 10.1016/j.metabol.2023.155665. Epub 2023 Jul 29.
3
评估可改变的风险因素对肝细胞癌的影响:来自双向孟德尔随机化分析的证据。
Discov Oncol. 2025 Mar 31;16(1):437. doi: 10.1007/s12672-025-02177-z.
4
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities.髓源性抑制细胞在肝癌中的免疫抑制作用:机制与治疗机遇
Cell Commun Signal. 2025 Mar 27;23(1):155. doi: 10.1186/s12964-025-02170-7.
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
短双歧杆菌产生的醋酸盐可抑制非酒精性脂肪性肝病相关肝细胞癌。
J Hepatol. 2023 Dec;79(6):1352-1365. doi: 10.1016/j.jhep.2023.07.005. Epub 2023 Jul 17.
4
Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis.早期生活肠道微生物群通过丁酸-IL-18 轴维持肝脏驻留自然杀伤细胞的成熟。
Nat Commun. 2023 Mar 27;14(1):1710. doi: 10.1038/s41467-023-37419-7.
5
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment.肠道微生物菌群失衡通过塑造肝脏炎症微环境促进肝癌发展。
Nat Commun. 2022 Jul 8;13(1):3964. doi: 10.1038/s41467-022-31312-5.
6
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
7
Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.脂联素-2 激活肝星状细胞,促进高脂饮食喂养的 Ob/Ob 小鼠非酒精性脂肪性肝炎。
Hepatology. 2023 Mar 1;77(3):888-901. doi: 10.1002/hep.32569. Epub 2023 Feb 17.
8
Epidemiology and risk-stratification of NAFLD-associated HCC.非酒精性脂肪性肝病相关肝细胞癌的流行病学和风险分层。
J Hepatol. 2021 Dec;75(6):1476-1484. doi: 10.1016/j.jhep.2021.08.012. Epub 2021 Aug 25.
9
Diet and exercise in NAFLD/NASH: Beyond the obvious.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的饮食和运动:超越显而易见的。
Liver Int. 2021 Oct;41(10):2249-2268. doi: 10.1111/liv.15024. Epub 2021 Aug 21.
10
Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells.使用人诱导多能干细胞建立与 PNPLA3 相关的非酒精性脂肪性肝病模型。
Hepatology. 2021 Dec;74(6):2998-3017. doi: 10.1002/hep.32063. Epub 2021 Sep 27.